Introduction
Breast cancer is a leading cause of morbidity and mortality in women, in developed and increasingly also developing countries (Siegel et al., 2013; Jemal et al., 2011) . Although many active cytotoxic agents are used in the treatment of breast cancer, their efficiency is limited because of drug resistance (Dean et al., 2005; Gonzalez-Angulo et al., 2007) . Therefore, the need for development of novel therapeutic or chemopreventive agents active against breast cancer remains an important goal. In recent years, using "food-based" approach to cancer chemoprevention has attracted a great deal of attention (Ramos 2008; Stan et al., 2008; Zhong et al., 2013) . triple-negative category, as defined by absent expression of these three proteins (Shao and Brown, 2004; Cleator et al., 2007) . The triple-negative breast cancer patients are typically treated with a combination of surgery, radiation therapy and chemotherapy. Current treatments for ER/PR-positive and HER2-positive breast cancers are not working (Cleator et al., 2007) . Therefore, scientists are still researching targeted treatments for triple-negative breast cancer.
In the present study, MCF-7 and MDA-MB-231 cell lines were employed as the cell model. MCF-7 cells are highly hormonedependent in growth and known to form well-differentiated tumors in a xenograft animal experimental model. MDA-MB-231 cells lack the expression of either estrogen receptor (ER) or progesterone receptor, which implies totally hormone-independent and poorlydifferentiated tumors in vivo (Bando et al., 2003 ) . (Håkansson, et al., 1995 The use of the α-lactalbumin-oleic acid complex for cancer therapy appears to be quite promising, considering the positive results obtained in the treatment of glioblastomas (Fischer et al., 2004) , skin papillomas , and bladder cancer (Mossberg et al., 2007; Mossberg et al., 2010) . However, most previous studies have been performed using the human milk protein. Some reports have shown that the bovine counterpart of HAMLET, bovine alpha-Lactalbumin-oleic acid complex (BLA-OA complex) shows similar tumoricidal activity to the HAMLET (Rammer et al., 2010; Zhang et al., 2010) . The possibility to prepare the cytotoxic protein-lipid complexes using bovine milk is of great importance for the putative future use of such compounds in clinics, because it will circumvent the problem of limited availability of human milk for large-scale production.
The aim of present study was to prepare the BLA-OA complex and investigate whether or not it could in vitro induce cytotoxic activity and apoptosis in ER-positive (MCF-7) and ER-negative 
Materials and Methods
Preparation of BLA-OA complex The BLA-OA complex was prepared by a modification of the method described by Brinkmann et al. (2011) . Firstly, α-lactalbumin (α-LA) was purified from fresh bovine milk. In brief, α-LA was purified by subjecting the whey fraction of bovine milk to two consecutive DEAE-Sepharose fast flow columns in the presence or absence of Ca 2+ on the first and at 490 nm wavelength and the cell growth was compared. DNA fragmentation analysis DNA gel electrophoresis was used to determine the presence of internucleosomal DNA cleavage.
Lactate dehydrogenase (LDH) release assay (Cytotoxicity) At
Briefly, the cells were treated with 100, 200 µg/mL of BLA-OA comlplex for 24h, which was followed by adding 400 μL of a lysis buffer (0.5% Triton X-100 in 10 mM EDTA, and 10 mM Tris-HCl, at 12,000 × g. The phenol extraction procedure was repeated three times. After adding 0.1 volume of 3 M sodium acetate, the DNA was precipitated with 2.5 volumes of cold ethanol overnight at _ 70℃. The mixture was centrifuged at 12,000 × g for 10 min, and then 700 μL of 70% ethanol was added to the pellet, which was shaken and centrifuged for 1 min at 12,000 × g. The pellet was treated with 30 μg/μL RNase A at 37℃ for 4 h. The DNA purity and concentration were determined by electrophoresis on 1% agarose gel containing 0.5 mg/mL ethidium bromide (EtBr; Sigma).
Images of the gel were obtained using a UV transilluminator and the Fujifilm LAS-3000 image system (Fujifilm Medical Systems,
Inc.).
Flow cytometry analysis Cells were plated at a density of 
Results
Cell growth inhibition and morphological changes by BLA-OA complex treatment.
The MCF-7 and MDA-MB-231 cell lines were treated with 25, 50, 100, 200, 400 µg/mL BLA-OA complex and it's components for 48 h to determine whether BLA-OA complex, oleic acid or α-lactalbumin caused a decrease in the number of cells. Fig. 1 shows that the BLA-OA complex treatment inhibited cell growth in a dose-dependent manner, as determined by the MTS assay. At 48 h, the maximum effect was observed with 400 µg/mL BLA-OA complex, which inhibited the proliferation of MCF-7 and MDA-MB-231 cells by 93.7% and 95.6%, respectively, while the native BLA or OA alone did not appear to have a significant effect on the cell growth (Fig. 1) . Cell morphology was evaluated under a microscope after treatment with 200 µg/mL BLA-OA complex for 24 h. Both cell lines in the treatment group were shrunken and round in shape with condensed nuclei. In addition, cell-to-cell contact was lost. The percentage of abnormal cells was much larger in the 200 µg/mL BLA-OA complex-treated group compared with the vehicle-treated group (Fig. 2) . These results suggest that the anti-proliferative effect of the BLA-OA complex treatment was associated with nuclear and cytosol shrinkage, which were determined to be apoptotic events (Dini et al., 1996) . (Fig. 3) .
Induced LDH release by the BLA-OA complex on breast cancer cells

Induction of DNA fragmentation by BLA-OA complex on breast
cancer cells In order to confirm whether the growth inhibitory effect of BLA-OA complex was due to apoptosis, breast cancer cells were treated with BLA-OA complex for 24h, and the nuclear morphological changes were analyzed using DAPI staining (Choi et al., 2001) . As shown in that appeared after 24 h of exposure (Fig. 5) .
Apoptosis was triggered by BLA-OA complex on breast cancer cells The apoptotic morphological change described above was also confirmed with a flow cytometric analysis, and the sub-G1 fraction was used as a measure of the apoptotic cells. After the breast cancer cells were treated with BLA-OA complex at designated concentrations (0, 25, 50, 100, 200 and 400 μg/mL) for 48h, they were harvested and stained with propidium iodide, and the cell populations of each phase were counted by flow cytometry.
As shown in Fig. 6 , the sub-G1 population, which indicated apoptotic cells, increased in dose dependent manner after exposure to BLA-OA complex for 48h. Although the G1 population decreased along with an increase of sub-G1, the other portion of non-apoptotic cells did not show a significant change. These results suggested that BLA-OA complex can induce apoptosis in breast cancer cells.
Discussion
Breast cancer is a heterogeneous group of diseases.
Approximately 60 _ 70% of breast cancers express estrogen receptors (ER) and/or progesterone receptors (PR) and Brenton et al., 2005) . These tumors are called triple-negative breast cancer and patients with these tumors have a poor prognosis (Brenton et al., 2005; Rahman et al., 2009 ).
There is no clinically validated, molecularly targeted therapy for these patients and they can be treated only with chemotherapy.
Thus, identification of novel, molecularly targeted therapies for triple-negative breast cancer would be of great benefit. In addition, a "food-based" approach to cancer chemoprevention is emerging as an attractive additional strategy for this disease control.
In the last few years, a remarkable apoptotic-like activity toward cultured cancer cells of a complex between the calcium-free form of human α-LA and oleic acid has been described (Mok et al., 2007) . The complex could either be isolated from human milk (Håkansson et al., 1995) or formed on a diethylaminoethyl trisacryl column equilibrated with OA (Svensson et al., 2000) . The complex was named human alpha-lactalbumin made lethal to tumor cells (HAMLET). When tested against several different cell types, HAMLET was reported by Svanborg et al. (2003) to show strongest activity against tumor cells, whereas mature differentiated cells were not affected. Accordingly, HAMLET appears to be a promising anti-cancer candidate. It is of great significance to be able to prepare the protein-lipid complex using bovine milk because it will allow large-scale production, circumventing the problem of limited availability of human milk. However, little information about the complex from bovine material has been presented.
In the present study, the BLA was purified from fresh bovine milk and the complex with oleic acid (BLA-OA complex) was prepared by a two-step chromatographic method. The cytotoxic and apoptotic activity of BLA-OA complex on human ER-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells was investigated. We demonstrated that BLA-OA complex is able to inhibit the growth of these cancer cell lines, while each of pure components (bovineα-lactalbumin and oleic acid) is inactive in the cell proliferation assay.
Induction of apoptosis is a useful approach in cancer therapies.
Apoptosis, a major process of programmed cell death, plays an important role in maintaining cellular homeostasis (Elmore, 2007; Lopez-Beltran et al., 2007) . Apoptosis or apoptosis-like cell death has previously been proposed as the major cytotoxic effector mechanism of HAMLET (Hallgren et al., 2006 (Hallgren et al., , 2008 . Previous studies have shown that the protein-lipid complex rapidly enters cancer cells and accumulates in the endolysosomal compartment, where it induces a lysosomal death pathway through leakage of lysosomal cathepsins into the cytosol (Rammer et al., 2010) . In our study, BLA-OA induced cell death was observed after several minuses. This rapid response, indicated as LDH release, could suggest that permeabilization of the plasma membrane may play a role in the induction of cell death, at least at high concentrations.
Furthermore, in apoptotic cells, several cellular and molecular biological features, such as cell shrinkage, DNA fragmentations, and activation of the caspase cascade, are exhibited (Germain et al., 1999) . In present study, we also observed cell shrinkage and DNA fragmentation, as determined by morphological observation, DAPI staining and DNA ladder assay, respectively. Regulation of the cancer cell cycle is one strategy in the development of anticancer drugs (Carnero, 2002) . In addition, cell cycle analyses of the BLA-OA complex-treated breast cancer cells showed significant cell arrest at sub-G1-phase in a dose-dependent manner, which indicating apoptosis.
In conclusion, we demonstrate that BLA-OA complex inhibits both human ER-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells growth and induces apoptosis. Although further study on the effects of BLA-OA on breast cancer is required, the findings of this study are positive for cow milk industry and human breast cancer chemoprevention.
